Trial Profile
Long-term efficacy of trastuzumab in patients with HER2+ metastatic breast cancer in community setting: A retrospective study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2014
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 13 Oct 2014 New trial record